Torchmark Corporation (NYSE:TMK) target price raised to $71.00, reported today by Zacks Investment Research
- Updated: September 27, 2016
Torchmark Corporation (NYSE:TMK) had its target price raised to $71.00 by Zacks Investment Research in a report released Tuesday September 27, 2016. The new target price indicates a possible upside of 0.12% based on the company's last stock close price.
Yesterday Torchmark Corporation (NYSE:TMK) traded 0.25% higher at $63.28. The company’s 50-day moving average is $63.64 and its 200-day moving average is $59.96. The last stock close price is up 5.66% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 96,341 shares of the stock were exchanged, down from an average trading volume of 534,939
See Chart Below
Torchmark Corporation has a 52 week low of $48.47 and a 52 week high of $65.60 with a P/E ratio of 14.57 The company’s market cap is currently $0.
About Torchmark Corporation (NYSE:TMK)
Torchmark Corporation is an insurance holding company. The Company, through its subsidiaries, provides a range of life and health insurance products and annuities to a broad base of customers. The Company's segments include life insurance, health insurance, annuities and investment. The life insurance segment offers whole-life insurance and term life insurance. The Health insurance products are guaranteed-renewable and include Medicare Supplement, critical illness, accident, long-term care and limited-benefit supplemental hospital and surgical coverage's. Annuities include fixed-benefit contracts. The Company markets its insurance products through various distribution channels, each of which sells the products of its insurance segments. Its primary subsidiaries are American Income Life Insurance Company, Liberty National Life Insurance Company, Globe Life And Accident Insurance Company, United American Insurance Company and Family Heritage Life Insurance Company of America.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.